Navigation Links
NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
Date:12/12/2010

, and other important variables that are not within the control of Nektar; (vii) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (viii) the uncertain outcome of any future intellectual property, commercial or other litigation related to Nektar's proprietary product candidates, including without limitation NKTR-102; and (ix) certain other important risks and uncertainties set forth in Nektar's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, filed on November 4, 2010.  Actual results could differ materially from the forward-looking statements contained in this press release.  Nektar undertakes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise.  

(1) Parkin D, Bray F, Ferlay J, et al: Global cancer statistics, 2001. CA Cancer J Clin 55:74-108, 2005.

(2) Alvaro and Perez, Mayo Clin Proc. 2009; 84(6):533-545

Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics

(650) 631-4954Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650Nektar Media Inquiries: Karen Bergman/BCC Partners

(650) 575-1509 Michelle Corral/BCC Partners

(415) 794-8662
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
2. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
3. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
4. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
5. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
6. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
7. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
10. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
11. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Alimera Sciences, Inc. (NASDAQ: ... specializes in the research, development and commercialization of ... the fourth quarter and year ended December 31, ... pivotal year for Alimera Sciences, most notably having ... for the treatment of diabetic macular edema," said ...
(Date:3/4/2015)... HEIGHTS, Mich. , March 4, 2015 ... provider of infusion pumps and related services for the ... fourth quarter and full year 2014 financial results on ... The Company will also conduct a conference call ... p.m. Eastern Time to discuss fourth quarter and full ...
(Date:3/4/2015)... , March 4, 2015 XBiotech announced ... study in patients with moderate to severe plaque ... open-label Phase II trial evaluated the potential benefit ... that targets interleukin-1 alpha (IL-1a). IL-1a is a ... present in skin lesions. The Company claims that ...
Breaking Medicine Technology:Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 14XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... reviewing the cardiovascular risks potentially associated with low testosterone ... Administration (FDA) announced that it will now require manufacturers ... increase their risk for heart attacks and strokes. In ... 2015, the agency also stated that it was requiring ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 " Optrix ... part of its monthly Tech Report, which takes a ... services available to consumers. Scott Steinberg, a special reporter ... review and shared with viewers how they have an ... The mobile industry is a major player at the ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The popular ... of their new L-Style Revolution™ Program. The customized program ... and women of all health and fitness levels to ... goals faster than traditional methods. , “We’re really proud ... customized plans based on award winning techniques to help ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... In a small ceremony with 20 attendees ... new facility in New Port Richey on February 24, 2015 ... will allow the Florida drug detox facility to ... epidemic through treatment and education. “Due to our unique medical-detox ... United States, we made the decision that expanding our facility ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... cardiovascular diseaseHOUSTON, Feb. 5 "I salute American Heart ... killer - cardiovascular diseases, including stroke. As a ... a clinical scientist and flight surgeon, I can attest ... and health care fields -- notably through the space ...
... SAN FRANCISCO, Calif., Feb. 5 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... Gower, the,company,s chairman and chief executive officer, is scheduled ... CEO & Investor Conference in New York,City on Monday, ... To access the live audio webcast or ...
... CHICAGO, Feb. 5 In recent years, Electronic Health ... as a means of improving patient care and controlling ... lower than expected due to general resistance related to ... studies have shown, however, that many of these adoption ...
... largest publisher of print guides to job boards, announced ... Health Care, the largest niche job board for USA ... this prestigious award for the third year in a ... multi-billion dollar global online employment services industry where actual ...
... billed as the world,s first hot pepper nasal spray when it was launched ... Allergy Buster are moving onto the shelves of more than 5,000 Rite Aid ... ... Sinus Buster as the world,s first hot pepper nasal spray in 2004 ...
... Networks, Inc. has announced that it has sold the rights to ... history tracking service, to nOOkist™. , ... New York, ... ), the company behind the popular MyBlackBook.Org service, has announced that ...
Cached Medicine News:Health News:Coalition for Space Exploration Salutes American Heart Month 2Health News:How to Select an Electronic Health Record System That Healthcare Professionals Can Use 2Health News:For the Third Year in a Row, Absolutely Health Care is Awarded a WEDDLE's User's Choice Award 2Health News:For the Third Year in a Row, Absolutely Health Care is Awarded a WEDDLE's User's Choice Award 3Health News:Sinus Buster Pepper Nasal Spray Moves Into Rite Aid Drug Stores 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3
... in 1937 with the Aviator style created ... Luxottica Group's brand portfolio in 1999. Worn ... since day one, Ray-Bans styles are sunglasses ... sunglasses in the world. Characterized by high ...
... manufacturing the Anne Klein brand under license ... are designed for an all-female market. The ... eyewear identifies herself with the typical modern ... who is image-conscious and quality-conscious and loves ...
... in mind, making eyewear that is kid-tough ... Its not surprising that Disney eyewear was ... selling childrens collection from 1997-2003. Part of ... ability to keep pace with todays fashion ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
Medicine Products: